Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models

Clinical and Translational Oncology

Volumn 16, Issue 8, 2014, Pages 714-724

  Ribes, J ^a,b   Esteban, L ^a   Cleries R ^a,b   Galceran, J ^c   Marcos Gragera, R ^d,e,f   Gispert, R ^g   Ameijide, A ^c   Vilardell, M L ^d,e   Borras, J ^c,h   Puigdefabregas, A ^g   Buxo M ^d,e,f   Freitas, A ^g   Izquierdo, A ^d,e   Borras, J M ^a,b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Registre de Càncer de Tarragona Fundació Lliga Per a la Investigació I Prevenció del Càncer ^*  (Spain)

^d GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^f UNIVERSITY OF GIRONA   (Spain)

^g Servei d'Informació I Estudis   (Spain)

^h UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Ageing; Cancer; Cancer risk; Incidence; Mortality; Projections

Indexed keywords

AGE DISTRIBUTION; AGING; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; DEMOGRAPHY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; POPULATION SIZE; PROSTATE CANCER; STOMACH CANCER; THYROID CANCER; TOBACCO; UTERINE CERVIX CANCER; UTERUS CANCER; ADULT; AGED; BAYES THEOREM; INCIDENCE; MIDDLE AGED; NEOPLASMS; REGISTER; SEX RATIO; SPAIN;

ADULT; AGE DISTRIBUTION; AGED; BAYES THEOREM; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SEX DISTRIBUTION; SPAIN;

EID: 84904507999     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1140-z     Document Type: Article

References (30)

1. Clèries R, Esteban L, Borràs J, Marcos-Gagera R, Freitas A, Carulla M, et al. Time trends of cancer incidence and mortality in Catalonia during 1993-2007. Clin Transl Oncol. 2013. doi:10.1007/s12094-013-1060-y.
2. Clèries R, Martinez JM, Moreno V, Yasui Y, Ribes J, Borras JM. Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach. Epidemiology. 2013;24(3):454-60.
3. Esteban L, Clèries R, Gálvez J, Pareja L, Escriba JM, Sanz X, et al. REGSTATTOOLS: freeware statistical tools for the analysis of disease population databases used in health and social studies. BMC Public Health. 2013;13(1):201.
4. Møller H, Fairley L, Coupland V, Okello C, Green M, Forman D, et al. The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007;96(9):1484-8. (Pubitemid 46685801)
5. Valls J, Clèries R, Galvez J, Moreno V, Gispert R, Borràs JM, et al. RiskDiff: a web tool for the analysis of the difference due to risk and demographic factors for incidence or mortality data. BMC Publ Health. 2009;9:473.
6. Bashir SA, Estève J. Analysing the difference due to risk and demographic factors for incidence or mortality. Int J Epidemiol. 2000;29:878-84.
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
8. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403.
9. Parkin DM. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S6-13.
10. Bray FI, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer. 2010;126:1454-66.
11. Schiaffino A, Fernandez E, Borrell C, Salto E, Garcia M, Borras JM. Gender and educational differences in smoking initiation rates in Spain from 1948 to 1992. Eur J Public Health. 2003;13(1):56-60. (Pubitemid 36356427)
12. López-Abente G, Ardanaz E, Torrella-Ramos A, Mateos A, Delgado-Sanz C, Chirlaque MD, et al. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol. 2010;21(Suppl 3):iii76-82.
13. Serra-Majem L, Ribas-Barba L, Salvador G, Jover L, Raidó B, Ngo J, et al. Trends in energy and nutrient intake and risk of inadequate intakes in Catalonia, Spain (1992-2003). Public Health Nutr. 2007;10(11A):1354-67. (Pubitemid 350085191)
14. Manchon-Walsh P, Borras JM, Espinas JA, Aliste L. Assessing the effectiveness of a guideline recommendation for pre-operative radiochemotherapy in rectal cancer. Radiother Oncol. 2011;99(2):142-7.
15. Mitry E, Bouvier AM, Esteve J, Faivre J. Improvement in colorectal cancer survival: a population-based study. Eur J Cancer. 2005;41(15):2297-303. (Pubitemid 41415606)
16. Bosch FX, Ribes J, Díaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 Suppl 1):S5-16.
17. Ribes J, Clèries R, Rubió A, Hernández JM, Mazzara R, Madoz P, et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer. 2006;119(3):687-94. (Pubitemid 43955725)
18. Althuis MD, Dozier JD, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol. 2005;34:405-12. (Pubitemid 40645331)
19. Parkin DM. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer. 2009;45:1649-53.
20. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-4. (Pubitemid 46631679)
21. Canfell K, Banks E, Moa AM, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust. 2008;188(11):641-44.
22. Pollán M, Pastor-Barriuso R, Ardanaz E, Argüelles M, Martos C, Galcerán J, et al. Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst. 2009;101(22):1584-91.
23. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borràs J, Clèries R, Ribes J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24(9):1083-8.
24. Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953-2008 - are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385-400.
25. Marcos-Gragera R, Pollan M, Chirlaque MD, Guma J, Sanchez MJ, Garau I, et al. Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain. Ann Oncol. 2010;21(Suppl 3):iii90-6.
26. Bertuccio P, Bosetti C, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. Int J Cancer. 2013;132(2):427-36.
27. Boseti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffeta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012;51:3-13.
28. Tyson MD, Humphreys MR, Parkers AS, Thiel DD, Joseph RW, Andrews PE, et al. Age-period-cohort analysis of renal cell carcinoma in United States adults. Urology. 2013;82(1):43-7.
29. Klint A, Tryggvadóttir L, Bray F, Gislum M, Hakulinen T, Storm HH, et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Actal Oncol. 2010;49(5):632-43.
30. Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, et al. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol. 2013;31(17):2146-51.